Journey Medical DERM
NASDAQ DERM
$5.22 +0.05 (+0.97%)
At close: Oct 20, 2026 · 4:00 PM EDT

Journey Medical (DERM) EBITDA (2020)

Updated

Journey Medical (DERM) reported EBITDA of -$32.38 million for FY2021, compared with $9.28 million in FY2020.

Analysis

Journey Medical (DERM) EBITDA (2020) Analysis & Trends

  • According to Business Quant data, EBITDA came in at $9.28 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 12.29 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 9.10 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 8.33 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 999.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 5.09 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 4.63 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -9.70 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 5.89 Bn
10 Journey Medical 144.34 Mn 42.43 Mn 12.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 3.95 Mn
Sep 30, 2020 640,000.00
API Access

Journey Medical EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=DERM&period=max&api_key=YOUR_API_KEY